Wen-Chien Chou Selected Research

Wen-Chien Chou Research Topics

Disease

31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2006
10	Neoplasms (Cancer) 01/2022 - 03/2004
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 11/2007
5	Leukemia 02/2019 - 07/2005
5	Acute Promyelocytic Leukemia 01/2017 - 03/2004
4	Disease Progression 01/2018 - 02/2014
3	Residual Neoplasm 01/2021 - 01/2012
2	Hematologic Neoplasms (Hematological Malignancy) 03/2022 - 01/2018
2	Multiple Myeloma 03/2022 - 08/2014
2	Lymphoma (Lymphomas) 03/2020 - 01/2007
2	Thrombocytopenia (Thrombopenia) 10/2019 - 07/2012
2	Infections 01/2019 - 12/2012
2	Diabetes Mellitus 01/2018 - 01/2015
2	Hepatitis B 01/2018 - 01/2015
2	Shock 05/2015 - 12/2012
1	Plasma Cell Neoplasms 03/2022
1	Osteolysis 03/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2022
1	B-Cell Leukemia (Leukemia, B Cell) 03/2020
1	Cytopenia 03/2020
1	Anemia 10/2019
1	Febrile Neutropenia 10/2019
1	Hepatitis 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2016
1	Hematologic Diseases (Blood Diseases) 11/2016
1	Erectile Dysfunction 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Invasive Fungal Infections 01/2015
1	Carcinogenesis 04/2013
1	Neoplasm Metastasis (Metastasis) 04/2013
1	Neutropenia 07/2012
1	Pathologic Complete Response 03/2011
1	Typhoid Fever (Typhoid) 05/2010
1	Psoas Abscess 05/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2010

Drug/Important Bio-Agent (IBA)

10	Biological ProductsIBA 02/2021 - 04/2010
4	Long Noncoding RNAIBA 02/2021 - 02/2019
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2015
3	ArsenicIBA 07/2005 - 03/2004
2	DecorinIBA 03/2022 - 01/2015
2	Rituximab (Mabthera)FDA Link 02/2022 - 01/2007
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 10/2019
2	gilteritinibIBA 01/2022 - 10/2019
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2015
2	GATA2 Transcription FactorIBA 01/2018 - 02/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 01/2016
2	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 04/2010
2	Pharmaceutical PreparationsIBA 07/2012 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 09/2011
2	NucleophosminIBA 01/2012 - 03/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2005 - 03/2004
1	Collagen Type I (Type I Collagen)IBA 03/2022
1	Bendamustine Hydrochloride FDA Link 02/2022
1	polatuzumab vedotinIBA 02/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	midostaurinIBA 01/2022
1	venetoclaxIBA 03/2020
1	AzolesIBA 03/2020
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	CohesinsIBA 12/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	Azacitidine (5 Azacytidine)FDA Link 10/2017
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 01/2017
1	RNA Splicing FactorsIBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Messenger RNA (mRNA)IBA 11/2015
1	LigandsIBA 01/2015
1	Small Leucine-Rich ProteoglycansIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 12/2014
1	Thalidomide (Thalomid)FDA Link 08/2014
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	Lenalidomide (CC 5013)FDA Link 08/2014
1	Bortezomib (Velcade)FDA Link 08/2014
1	Carrier Proteins (Binding Protein)IBA 02/2014
1	Lipocalin-2IBA 08/2013
1	Galectin 3 (LGALS3)IBA 04/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2012
1	Decitabine FDA Link 07/2012
1	CCAAT-Enhancer-Binding Protein-alphaIBA 09/2011
1	Contrast MediaIBA 03/2011
1	Indicators and Reagents (Reagents)IBA 03/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2010

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Induction Chemotherapy 01/2021 - 04/2009
4	Therapeutics 01/2018 - 01/2005
2	Homologous Transplantation 01/2018 - 12/2012
2	Hematopoietic Stem Cell Transplantation 01/2018 - 11/2016
1	Withholding Treatment 02/2022
1	Immunotherapy 01/2022
1	Duration of Therapy 10/2019
1	Stem Cell Transplantation 01/2019
1	Aftercare (After-Treatment) 11/2018
1	Catheters 05/2015
1	Transplantation 11/2014
1	Central Venous Catheters 12/2012